Susan Wood

Matthew’s Friends Clinics

Susan Wood has worked as a UK registered dietitian for 36 years predominantly in the NHS, treating a wide range of paediatric and adult conditions.

In 2008, the referral of one young adult for the dietary management of drug resistant epilepsy sparked her interest in ketogenic diet therapy (KDT) and since then she has been pioneering the development of adult treatment protocols in the UK and raising the awareness of dietitians and adult neurologists to the potential that KDT can offer to adults.

In 2009 she started to work alongside the Matthews Friends Charity, offering support to adults and their neurology teams seeking treatment and in 2011 she joined the newly formed clinical team at the Matthews Friends Centre for Ketogenic Dietary Therapies. She continues to lead on the treatment of adults with complex epilepsy and the exploration of novel clinical applications for KDT.

dont miss

Ketogenic Diet Therapy in Adults; complex epilepsy and beyond.

The seminar will address the pros, cons and practicalities of Ketogenic Diet Therapy use in adults; focussing on drug resistant epilepsy and use as an adjuvant approach in brain tumour management.

EVEN MORE SEMINARS

  • Dinithi O’Gorman: Speaking at the European Neurological Convention

    Dinithi O’Gorman
    Priory Group

    Benefits of Speech and Language Therapy in Neuro Rehabilitation

  • Dr Jenny Brooks: Speaking at the European Neurological Convention

    Dr Jenny Brooks
    The ABI Team

    Neurobehavioural Rehabilitation In The Community

  • Dr Anita Rose: Speaking at the European Neurological Convention

    Dr Anita Rose
    The Raphael Hospital

    Mental Health and Brain Injury: Promoting mental wellbeing

  • Ali Gibson: Speaking at the European Neurological Convention

    Ali Gibson
    Stoke Mandeville Spinal Research

    TBC

  • Ali Mazaheri: Speaking at the European Neurological Convention

    Ali Mazaheri
    Centre for Human Brain Health, University of Birmingham

    EEG oscillations during word processing can predict vulnerability to Alzheimer’s disease”